Serological Protection 5–6 Years Post Vaccination Against Yellow Fever in African Infants Vaccinated in Routine Programmes

Abstract

Introduction: Although effective live attenuated yellow fever (YF) vaccines have been available for over 9 decades sporadic outbreaks continue to occur in endemic regions. These may be linked to several factors including epidemiological factors such as vector and intermediate host distribution or vaccine coverage and efficacy. The World Health Organization's research priorities include gathering systematic evidence around the potential need for booster vaccination with YF vaccine whether this follows full or fractional doses in children. Knowledge on the longevity of response to YF vaccine and the implications of this response needs to be consolidated to guide future vaccination policy. Methods: We measured anti-YF IgG by microneutralization assay in a group of 481 African infants who had received YF vaccine as part of routine EPI programmes, to explore serological protection from YF 5–6 years post YF vaccination, as well as the effect of co variates. Findings: Notably, 22.2% of the cohort had undetectable antibody concentrations, with another 7.5% revealing concentrations below the threshold of seropositivity of 0.5 IU/mL. Sex, season, country and time since vaccination did not affect the longevity of antibody concentration or having antibody concentrations above a defined threshold. Conclusion: Roughly 30% of children in this cohort did not demonstrate anti-yellow fever antibody concentrations above the defined threshold of protection, with 20% having no demonstrable antibody. Knowledge on the longevity of response to YF vaccine and the implications needs to be consolidated to guide future vaccination policy.

Laboratory and Greenhouse Performance of Five Commercial Light Traps for Capturing Mosquitoes in China

“…Of the over 50 mosquito-borne diseases known, vaccines are available only for epidemic encephalitis and yellow fever. The basic way to curb other mosquito-borne diseases is mosquito control (Baldacchino et al 2015, Oliveira et al 2019, de Thoisy et al 2020, Idoko et al 2020, Trovato et al 2020. During mosquito season or a mosquito-borne disease epidemic, it is necessary not only to implement integrated mosquito control in the external environment, but also to control mosquitoes and prevent bites in residential homes.…”

Re-emergence of yellow fever in the neotropics — quo vadis?

“…Vaccination is recommended for persons of 9 months of age and older and a single dose of the vaccine with boosters every 10 years is highly efficacious and confers life-long protection against YFV [66]. However, recent studies suggested limited serologic protection in children after vaccination [67,68]. In 2013, WHO recommended that a single dose is sufficient to elicit life-long protection [69], and booster doses should be determined on a case-by-case basis and restricted to special populations, including young children, pregnant women, and immunocompromised individuals [70,71].…”

Laboratory and Field Performance of Five Cheap Commercial Light Traps for Capturing Mosquitoes In China

“…Of the more than 50 known mosquito-borne diseases, vaccines are available only for epidemic encephalitis and yellow fever. The Basic way to curb other mosquito-borne diseases is mosquito control [5,6,7,8,9]. During mosquito season or a mosquito-borne disease epidemic, it is necessary not only to implement integrated mosquito control in the external environment, but also to control mosquitoes and prevent bites in residential homes.…”